Business Context and Reporting Period
Company: IDEAYA Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 23, 2021
Reporting Period: Fourth quarter ended December 31, 2020
Context: The filing announces financial results for the fourth quarter of 2020. The full details are contained in a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the Form 8-K and does not contain specific numerical data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached Exhibit 99.1 (Press Release), which is not included in the input content.
Material Changes
No material changes or comparative financial data versus prior periods are disclosed in the provided text. The document serves only to notify the SEC of the announcement of results.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release for the full announcement but does not include management commentary, guidance, or outlook within the text provided.
Risks and Contingencies: No specific risks or contingencies are detailed in this excerpt.
Unusual Items: None reported in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 23, 2021) for actual financial figures, as they are absent from the 8-K cover sheet.
- Verify the company's status as an "Emerging Growth Company" (indicated as checked in the filing).
- Confirm the trading symbol (IDYA) and exchange (Nasdaq Global Select Market) for accurate market data retrieval.
- Check subsequent filings for the full text of the press release if not immediately available.